Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
In Vivo
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
In Vivo

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin

Antisense

  • You have access
    Suppression of BCL2 by Antisense Oligonucleotides and Compensation by Non-Targeted Genes May Enhance Tumor Proliferation
    MARVIN RUBENSTEIN, COURTNEY M. P. HOLLOWELL and PATRICK GUINAN
    In Vivo November 2015, 29 (6) 687-693;
  • You have access
    Additional Compensatory Mechanisms Altering Antisense Oligonucleotide Suppression of BCL2: Effects upon AKT1 and STAT3
    MARVIN RUBENSTEIN, COURTNEY M. P. HOLLOWELL and PATRICK GUINAN
    In Vivo September 2014, 28 (5) 867-870;
  • You have access
    No Compensation in CD44 Stem Cell Marker Following BCL-2 Suppression By Antisense Oligonucleotides
    MARVIN RUBENSTEIN, COURTNEY M.P. HOLLOWELL and PATRICK GUINAN
    In Vivo March 2013, 27 (2) 251-256;
  • You have access
    No Compensation in VEGF Expression Follows Antisense Suppression of BCL-2 Activity
    MARVIN RUBENSTEIN, COURTNEY M.P. HOLLOWELL and PATRICK GUINAN
    In Vivo November 2012, 26 (6) 937-940;
In Vivo

© 2026 In Vivo

Powered by HighWire